Sign inJoin waitlistJoin the waitlist

Manasa Vulchi

Physician · Eisenhower Medical Center

Credentials: · · · · · ·

History

Eisenhower Medical Center
2023–Present

Cleveland Clinic Foundation
2015–2017
MedStar Union Memorial Hospital
2012–2015
Doctor of Medicine
2005–2009

Research

Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer
JAMA Network Open · 2019 · 284 citations
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Clinical Cancer Research · 2022 · 29 citations
The changing anatomic position of squamous cell carcinoma of the lung - a new conundrum
Journal of Community Hospital Internal Medicine Perspectives · 2016 · 18 citations

Donna Plecha
2 papers
Jame Abraham
2 papers
KB
Kaustav Bera
2 papers · 1 as a resident
ME
Maryam Etesami
2 papers
Paulette Turk
2 papers
PP
Prateek Prasanna
2 papers · 2 as a resident
Amit Gupta
1 paper
BB
Boris Bloch
1 paper
DH
Daniel Harley
1 paper
DB
David Bates
1 paper
GS
George Somlo
1 paper
Hannah Gilmore
1 paper

Clinical trials

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
E-Mindfulness Approaches for Living After Breast Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2030
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033